Maze Therapeutics, a clinical-stage biopharmaceutical company harnessing the power of human genetics to develop novel, small molecule precision medicines for patients living with common diseases, ...

Pioneering Study in Parkinson's Disease to Advance Surgical Treatment Options RebrAIn, a leader in precise targeting solutions for deep brain stimulation (DBS) and lesion techniques, today announced ...

Durham, North Carolina Tuesday, October 1, 2024, 18:00 Hrs [IST] ...

Announced strategic financing with Arena Investors, providing access to up to $59.0 million USD in gross proceeds to Incannex Announced positive top-line results from our Phase 2 proof-of-concept clin ...

A number of recent clinical trials have suggested that gene therapy could help treat diseases of the eye that cause vision ...

The trial (NCT06053840) enrolled 100 adult patients who received chloral hydrate treatment over 14 days and came from primary and secondary care sites. Patients were closely monitored by a virtual ...

Curium, a world leader in nuclear medicine, announced today that it has entered into a strategic partnership with PDRadiopharma Inc, a wholly-owned subsidiary of PeptiDream, for the clinical ...

When working with clinical trial data, converting raw data into the standardized Study Data Tabulation Model (SDTM) format is a crucial step.